benserazide has been researched along with droxidopa in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (50.00) | 18.7374 |
| 1990's | 9 (40.91) | 18.2507 |
| 2000's | 1 (4.55) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Araki, H; Cheng, JT; Ohmura, I; Tanaka, C | 1 |
| Falck, B; Hardebo, JE; Owman, C | 1 |
| Altier, H; Moldes, M; Monti, JM | 1 |
| Blalock, JA; Feldman, JM; Henderson, JH | 1 |
| Bartholini, J; Constantinidis, J; Pletscher, A; Puig, M; Tissot, R | 1 |
| Azuma, T; Hiraga, T; Kishimoto, S; Kobayashi, T; Matsubara, T; Mizuno, R; Sakoda, S; Suzuki, T; Tsujino, S; Yoshida, S | 1 |
| Hisaki, K; Ichihara, T; Matsumura, Y; Morimoto, S; Ohyama, T; Shinyama, H; Takahashi, Y | 1 |
| Kato, T; Katsube, J; Katsuyama, M; Maeda, Y; Nakamura, M; Nishikawa, S | 1 |
| Karai, N; Kato, T; Katsube, J; Katsuyama, M; Nakamura, M | 1 |
| Fukuda, H; Nagano, N; Nakamura, T; Ono, H; Tanabe, M | 1 |
| Edwards, DJ; Sedlock, ML | 1 |
| Birkmayer, G; Birkmayer, W; Lechner, H; Riederer, P | 1 |
| Kuroda, H; Nukina, I; Ogawa, N; Ota, Z; Yamamoto, M | 1 |
| Kasamatsu, K; Kawabata, A; Takagi, H; Umeda, N | 1 |
| Abe, K; Itoyama, Y; Kogure, K; Lee, TH; Nakamura, M | 1 |
| Abe, K; Aoki, M; Itoyama, Y; Kogure, K; Lee, TH; Nakamura, M | 1 |
| Hazemeijer, I; Korf, J; Lakke, JP; Verhagen-Kamerbeek, WD | 1 |
| Soares-da-Silva, P | 1 |
| Fukamauchi, K; Imamura, K; Mataga, N; Shiomitsu, T; Watanabe, Y; Yoshimura, Y | 1 |
| Kikuchi, K; Nishino, K; Ohyu, H | 2 |
| Dela Peña, I; Shen, G; Shi, WX | 1 |
22 other study(ies) available for benserazide and droxidopa
| Article | Year |
|---|---|
Positive chronotropic effect of threo-3,4-dihydroxyphenylserine as a precursor of noradrenaline in rat isolated atria.
Topics: Animals; Benserazide; Droxidopa; Heart Rate; In Vitro Techniques; Male; Methyltyrosines; Myocardium; Norepinephrine; Rats; Serine; Stereoisomerism; Stimulation, Chemical; Time Factors | 1978 |
A comparative study on the uptake and subsequent decarboxylation of monoamine precursors in cerebral microvessels.
Topics: 5-Hydroxytryptophan; Animals; Aromatic-L-Amino-Acid Decarboxylases; Benserazide; Blood-Brain Barrier; Brain; Cats; Cattle; Cricetinae; Decarboxylation; Dogs; Droxidopa; Female; Guinea Pigs; Haplorhini; Humans; Levodopa; Male; Mice; Microcirculation; Microscopy, Fluorescence; Rabbits; Rats; Serine; Species Specificity; Swine | 1979 |
The actions of dihydroxyphenylalanine and dihydroxyphenylserine on the sleep-wakefulness cycle of the rat after peripheral decarboxylase inhibition.
Topics: Activity Cycles; Animals; Benserazide; Carboxy-Lyases; Circadian Rhythm; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Droxidopa; Electroencephalography; Male; Rats; Serine; Sleep; Sleep Stages; Sleep, REM; Wakefulness | 1975 |
Effect of pharmacological agents and fasting on pancreatic islet norepinephrine in the golden hamster.
Topics: Animals; Benserazide; Blood Glucose; Catechol O-Methyltransferase; Cricetinae; Droxidopa; Fasting; In Vitro Techniques; Islets of Langerhans; Mesocricetus; Monoamine Oxidase; Norepinephrine; Reserpine; Tranylcypromine | 1979 |
The stereoisomers of 3,4-dihydroxyphenylserine as precursors of norepinephrine.
Topics: Animals; Behavior, Animal; Benserazide; Brain; Brain Chemistry; Carbidopa; Carboxy-Lyases; Dopamine; Droxidopa; Female; Histocytochemistry; In Vitro Techniques; Male; Myocardium; Norepinephrine; Rats; Serine; Serotonin; Stereoisomerism | 1975 |
Effect of long-term L-threo-3,4-dihydroxyphenylserine administration on alpha 2-adrenergic receptors in platelet membranes in neurologic disorders.
Topics: Aged; Amyloidosis; Benserazide; Blood Platelets; Dose-Response Relationship, Drug; Droxidopa; Drug Therapy, Combination; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Muscular Atrophy; Nervous System Diseases; Neurologic Examination; Norepinephrine; Parkinson Disease; Polyneuropathies; Receptors, Adrenergic, alpha; Yohimbine | 1991 |
Diuretic effects of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) in anesthetized rats.
Topics: Anesthesia; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Blood Pressure; Diuretics; Droxidopa; Glomerular Filtration Rate; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Norepinephrine; Phentolamine; Rats; Rats, Inbred Strains; Renal Circulation; Serine | 1990 |
Diuretic effect of L-threo-3,4-dihydroxyphenylserine, a noradrenaline precursor, in rats and mice.
Topics: Animals; Benserazide; Carbidopa; Diuretics; Dose-Response Relationship, Drug; Droxidopa; Drug Interactions; Male; Mice; Norepinephrine; Rats; Rats, Inbred Strains; Serine; Species Specificity | 1986 |
Effect of L-threo-3,4-dihydroxyphenylserine(L-threo-DOPS) on brain and serum MHPG levels in mice: evidence for NE formation in CNS.
Topics: Animals; Benserazide; Brain; Brain Chemistry; Dose-Response Relationship, Drug; Droxidopa; Glycols; Male; Methoxyhydroxyphenylglycol; Mice; Norepinephrine; Serine | 1987 |
Effects of L-threo-dihydroxyphenylserine on spinal reflexes and decerebrate rigidity in rats.
Topics: Animals; Benserazide; Blood Pressure; Clorgyline; Decerebrate State; Droxidopa; Male; Motor Activity; Rats; Rats, Inbred Strains; Reflex; Serine; Spinal Cord | 1988 |
Increased brain concentration of homovanillic acid in rats treated with threo-3,4-dihydroxyphenylserine.
Topics: Animals; Benserazide; Brain Chemistry; Droxidopa; Homovanillic Acid; Male; Norepinephrine; Phenylacetates; Rats; Rats, Inbred Strains; Serine | 1982 |
DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizziness.
Topics: Aged; Antiparkinson Agents; Benserazide; Blood Pressure; Dizziness; Droxidopa; Drug Therapy, Combination; Female; Humans; Hypotension, Orthostatic; Long-Term Care; Male; Norepinephrine; Parkinson Disease; Serine | 1983 |
Improvement in freezing phenomenon of Parkinson's disease after DL-threo-3, 4-dihydroxyphenylserine.
Topics: Aged; Benserazide; Droxidopa; Gait; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Parkinson Disease; Serine | 1984 |
The noradrenaline precursor L-threo-3,4-dihydroxyphenylserine exhibits antinociceptive activity via central alpha-adrenoceptors in the mouse.
Topics: Administration, Oral; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Analgesics; Animals; Benserazide; Droxidopa; Injections, Intraventricular; Injections, Spinal; Injections, Subcutaneous; Male; Mice; Mice, Inbred Strains; Naloxone; Pain Measurement; Receptors, Adrenergic, alpha; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Spinal Cord | 1994 |
Reduction of nerve growth factor receptor immunoreactivity in ischaemic gerbil hippocampal CA1 neurons after treatment with L-threo-3,4-dihydroxyphenylserine (DOPS).
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Blotting, Western; Brain Ischemia; Cerebrovascular Circulation; Droxidopa; Gerbillinae; Hippocampus; Immunohistochemistry; Male; Neurons; Receptors, Nerve Growth Factor | 1994 |
The protective effect of L-threo-3,4-dihydroxyphenylserine on ischemic hippocampal neuronal death in gerbils.
Topics: Animals; Benserazide; Brain Ischemia; Cell Death; Droxidopa; Gerbillinae; Heat-Shock Proteins; Hippocampus; Male; Nerve Growth Factors; Neurons; Receptors, Nerve Growth Factor | 1994 |
Attenuation of haloperidol-induced catalepsy by noradrenaline and L-threo-DOPS.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Benzophenones; Catalepsy; Catechol O-Methyltransferase Inhibitors; Droxidopa; Drug Interactions; Haloperidol; Male; Nitrophenols; Norepinephrine; Postural Balance; Rats; Rats, Wistar; Tolcapone | 1993 |
Preferential decarboxylation of L-threo-3,4-dihydroxyphenylserine in rat renal tissues.
Topics: Animals; Aromatic-L-Amino-Acid Decarboxylases; Benserazide; Droxidopa; Heart Ventricles; Jejunum; Kidney; Kidney Cortex; Liver; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Oxidopamine; Rats; Rats, Wistar | 1993 |
Enhancement of mRNA expression of tissue-type plasminogen activator by L-threo-3,4-dihydroxyphenylserine in association with ocular dominance plasticity.
Topics: Animals; Antiparkinson Agents; Benserazide; Blotting, Northern; Cats; Droxidopa; Gene Expression; Male; Neuronal Plasticity; Plasminogen Activators; Rats; Rats, Wistar; RNA, Messenger; Sensory Deprivation; Tissue Plasminogen Activator; Vision, Monocular; Visual Cortex; Visual Pathways | 1996 |
L-DOPS-Accelerated recovery of locomotor function in rats subjected to sensorimotor cortex ablation injury: pharmacobehavioral studies.
Topics: Animals; Benserazide; Brain; Cerebral Cortex; Dopamine Agents; Droxidopa; Drug Therapy, Combination; Levodopa; Male; Methoxyhydroxyphenylglycol; Motor Activity; Norepinephrine; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Stroke | 1999 |
Increasing CNS norepinephrine levels by the precursor L-DOPS facilitates beam-walking recovery after sensorimotor cortex ablation in rats.
Topics: Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Brain; Brain Injury, Chronic; Cerebellum; Cerebral Cortex; Dominance, Cerebral; Droxidopa; Enzyme Inhibitors; Hemiplegia; Hippocampus; Male; Motor Cortex; Norepinephrine; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Somatosensory Cortex | 2000 |
Droxidopa alters dopamine neuron and prefrontal cortex activity and improves attention-deficit/hyperactivity disorder-like behaviors in rats.
Topics: Animals; Attention; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Benserazide; Delay Discounting; Disease Models, Animal; Dopamine Agents; Dopaminergic Neurons; Droxidopa; Drug Therapy, Combination; Locomotion; Male; Maze Learning; Prefrontal Cortex; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Species Specificity; Ventral Tegmental Area | 2021 |